213 related articles for article (PubMed ID: 22703762)
1. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome.
Cay HF; Sezer I; Dogan S; Felek R; Aslan M
Clin Exp Rheumatol; 2012; 30(6):843-9. PubMed ID: 22703762
[TBL] [Abstract][Full Text] [Related]
2. No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome.
Gottenberg JE; Sellam J; Ittah M; Lavie F; Proust A; Zouali H; Sordet C; Sibilia J; Kimberly RP; Mariette X; Miceli-Richard C
Arthritis Res Ther; 2006; 8(1):R30. PubMed ID: 16507129
[TBL] [Abstract][Full Text] [Related]
3. TNFR1-383 A˃C polymorphism association with clinical manifestations in primary Sjögren's syndrome patients.
Fletes-Rayas AL; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Oregon-Romero E
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323176
[TBL] [Abstract][Full Text] [Related]
4. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.
Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X
Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501
[TBL] [Abstract][Full Text] [Related]
5. IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome.
Ou TT; Lin CH; Lin YC; Li RN; Tsai WC; Liu HW; Yen JH
J Clin Immunol; 2008 Sep; 28(5):440-4. PubMed ID: 18600435
[TBL] [Abstract][Full Text] [Related]
6. Presence of apolipoprotein E epsilon4 allele predisposes to early onset of primary Sjogren's syndrome.
Pertovaara M; Lehtimäki T; Rontu R; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2004 Dec; 43(12):1484-7. PubMed ID: 15328426
[TBL] [Abstract][Full Text] [Related]
7. Th1 and Th2 polymorphisms in Sjögren's syndrome and rheumatoid arthritis.
de Souza TR; de Albuquerque Tavares Carvalho A; Duarte ÂP; Porter SR; Leão JC; Gueiros LA
J Oral Pathol Med; 2014 Jul; 43(6):418-26. PubMed ID: 24393164
[TBL] [Abstract][Full Text] [Related]
8. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
9. CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren's syndrome.
Petrek M; Cermáková Z; Hutyrová B; Miceková D; Drábek J; Rovensky J; Bosák V
Clin Exp Rheumatol; 2002; 20(5):701-3. PubMed ID: 12412204
[TBL] [Abstract][Full Text] [Related]
10. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjögren's syndrome and correlate with the clinical manifestations of the disease.
Hulkkonen J; Pertovaara M; Antonen J; Pasternack A; Hurme M
Rheumatology (Oxford); 2001 Jun; 40(6):656-61. PubMed ID: 11426023
[TBL] [Abstract][Full Text] [Related]
11. FAS -670A>G promoter polymorphism is associated with soluble Fas levels in primary Sjögren's syndrome.
Treviño-Talavera BA; Palafox-Sánchez CA; Muñoz-Valle JF; Orozco-Barocio G; Navarro-Hernández RE; Vázquez-Del Mercado M; García de la Torre I; Oregon-Romero E
Genet Mol Res; 2014 Jul; 13(3):4831-8. PubMed ID: 25062418
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the tumour necrosis factor-alpha gene at position -308 and renal manifestations of primary Sjögren's syndrome.
Pertovaara M; Hulkkonen J; Antonen J; Holopainen P; Laippala P; Pasternack A; Hurme M
Rheumatology (Oxford); 2004 Jan; 43(1):106-7. PubMed ID: 14681562
[No Abstract] [Full Text] [Related]
13. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
14. IL-10 promoter -1082 polymorphism is associated with elevated IL-10 levels in control subjects but does not explain elevated plasma IL-10 observed in Sjögren's syndrome in a Hungarian cohort.
Márka M; Bessenyei B; Zeher M; Semsei I
Scand J Immunol; 2005 Nov; 62(5):474-80. PubMed ID: 16305644
[TBL] [Abstract][Full Text] [Related]
15. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome.
Hulkkonen J; Pertovaara M; Antonen J; Lahdenpohja N; Pasternack A; Hurme M
Arthritis Rheum; 2001 Jan; 44(1):176-9. PubMed ID: 11212157
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjögren's syndrome.
Tobón GJ; Correa PA; Gomez LM; Anaya JM
Clin Exp Rheumatol; 2005; 23(3):339-44. PubMed ID: 15971421
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sjogren's syndrome.
Hulkkonen J; Pertovaara M; Antonen J; Pasternack A; Hurme M; Pöllänen P; Lehtimäki T
Rheumatology (Oxford); 2004 Dec; 43(12):1476-9. PubMed ID: 15316122
[TBL] [Abstract][Full Text] [Related]
18. No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjögren's syndrome.
Ittah M; Gottenberg JE; Proust A; Hachulla E; Puechal X; Loiseau P; Mariette X; Miceli-Richard C
Genes Immun; 2005 Aug; 6(5):457-8. PubMed ID: 15933742
[TBL] [Abstract][Full Text] [Related]
19. Analysis of TNFalpha microsatellites in 35 patients with primary Sjögren's syndrome.
Guggenbuhl P; Veillard E; Quelvenec E; Jego P; Semana G; Jean S; Meadeb J; Chalès G; Perdriger A
Joint Bone Spine; 2000; 67(4):290-5. PubMed ID: 10963076
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism.
Correa PA; Gomez LM; Cadena J; Anaya JM
J Rheumatol; 2005 Feb; 32(2):219-24. PubMed ID: 15693080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]